REaCT Integrated Consent Model to Compare Two Standard of Care Regimens

NCT02173262 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

142

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: G-CSF
DRUG: Ciprofloxacin

Sponsor

Ottawa Hospital Research Institute